Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05837676 · ClinicalTrials.gov registry record · NA

Problem-Solving Training for Concussion

A NA study of Brain Concussion, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
134
Enrollment target
1
Study location

NCT05837676: Recruiting NA study of Brain Concussion, sponsored by VA Office of Research and Development.

NCT05837676 is a NA study of Brain Concussion that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 134 participants, below the 290-participant average among 17 other Brain Concussion trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05837676, a NA study of Brain Concussion, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
134 participants
Enrollment target
1
Study location

Study Summary

Mild traumatic brain injury (mTBI), also known as concussion, is a common injury sustained by Veterans. While most individuals who sustain mTBI experience a complete recovery within several weeks of injury, many Veterans with history of mTBI report frequent and long-lasting neurobehavioral complaints and functional impairment. Though research suggests that these outcomes are strongly influenced by co-occurring conditions such as post-traumatic stress disorder, depression, and chronic pain, evidence-based interventions capable of addressing this wide array of concerns are lacking. This study seeks to address this gap by evaluating the effectiveness of a brief and flexible behavioral health treatment (Problem-Solving Training for Concussion, or PST-Concussion), which was designed to be delivered by generalist providers working in VA primary care settings. If PST-Concussion is shown to be effective, this skills-focused intervention may help improve Veterans' recovery experience following mTBI.

Primary Outcome

The BSI-18 is a brief measure of psychological distress brought about by common somatic and affective symptoms. It has been validated for use in patients with history of TBI and is appropriate for use in primary care. Similar to a previous trial of PST for mTBI, its Global Severity Index (GSI) T-score will serve as the primary outcome measure. GSI T-scores range from 30-80, with lower scores signaling an overall lower level of psychological distress.

Conditions Studied

Interventions

  • OTHER Treatment as usual
  • BEHAVIORAL Problem Solving Training for Concussion

Study Locations (1)

New York

  • VA Western New York Healthcare System, Buffalo, NY - Buffalo

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2023-10-01
Est. Completion 2027-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05837676 shows while recruiting

NCT05837676 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 290-participant average among 17 other Brain Concussion trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Brain Concussion appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT05837676 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05837676 about?

NCT05837676 is a clinical study titled "Problem-Solving Training for Concussion". Mild traumatic brain injury (mTBI), also known as concussion, is a common injury sustained by Veterans. While most individuals who sustain mTBI experience a complete recovery within several weeks of injury, many Veterans with history of mTBI report frequent and long-lasting neurobehavioral complaint...

What is the current status of trial NCT05837676?

This trial is currently recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2023-10-01. Estimated completion is 2027-09-30.

What conditions does trial NCT05837676 study?

This clinical trial studies the following conditions: Brain Concussion.

What interventions are being tested in trial NCT05837676?

The interventions under investigation include: Treatment as usual (OTHER), Problem Solving Training for Concussion (BEHAVIORAL).

Who is sponsoring clinical trial NCT05837676?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05837676 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Concussion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05837676's enrollment target sits among peer trials

134 7th of 17 higher than 11 of 17 other Brain Concussion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Concussion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02469662 · 134 participants · NA

    Clinical Outcomes Study of the Nexel Total Elbow

  • NCT03110822 · 134 participants · Phase 1

    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

  • NCT04678648 · 134 participants · Phase 1

    A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • NCT05264857 · 134 participants · NA

    Decision Aid and Thyroid Nodules Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05837676, the US trial registry maintained by the National Library of Medicine. NCT05837676 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.